References
- Roffman JL , NitensonAZ, AgamYet al. A hypomethylating variant of MTHFR, 677C>T, blunts the neural response to errors in patients with schizophrenia and healthy individuals. PLoS ONE 6(9) , e25253 (2011).
- Roffman JL , GollubRL, CalhounVDet al. MTHFR 677C --> T genotype disrupts prefrontal function in schizophrenia through an interaction with COMT 158Val --> Met. Proc. Natl Acad. Sci. USA 105(45) , 17573–17578 (2008).
- Ellingrod VL , TaylorSF, DalackGet al. Risk factors associated with metabolic syndrome in bipolar and schizophrenia subjects treated with antipsychotics: the role of folate pharmacogenetics. J. Clin. Psychopharmacol. 32(2) , 261–265 (2012).
- Ellingrod VL , MillerDD, TaylorSF, MolineJ, HolmanT, KerrJ. Metabolic syndrome and insulin resistance in schizophrenia patients receiving antipsychotics genotyped for the methylenetetrahydrofolate reductase (MTHFR) 677C/T and 1298A/C variants. Schizophr. Res.98(1–3) , 47–54 (2008).
- van Winkel R , RuttenBP, PeerboomsO, PeuskensJ, van Os J, De Hert M. MTHFR and risk of metabolic syndrome in patients with schizophrenia. Schizophr. Res.121(1–3) , 193–198 (2010).
- Frankenburg FR . The role of one-carbon metabolism in schizophrenia and depression. Harv. Rev. Psychiatry15(4) , 146–160 (2007).
- Chen J , LipskaBK, HalimNet al. Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am. J. Hum. Genet. 75(5) , 807–821 (2004).
- Roffman JL , WeissAP, DeckersbachTet al. Interactive effects of COMT Val108/158Met and MTHFR C677T on executive function in schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B(6) , 990–995 (2008).
- Roffman JL , WeissAP, PurcellSet al. Contribution of methylenetetrahydrofolate reductase (MTHFR) polymorphisms to negative symptoms in schizophrenia. Biol. Psychiatry 63(1) , 42–48 (2008).
- Roffman JL , WeissAP, DeckersbachTet al. Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia. Schizophr. Res. 92(1–3) , 181–188 (2007).
- Colton C , ManderscheidR. Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states. Prev. Chronic Dis.3(2) , A42 (2006).
- Ray WA , ChungCP, MurrayKT, HallK, SteinCM. Atypical antipsychotic drugs and the risk of sudden cardiac death. N. Engl. J. Med.360(3) , 225–235 (2009).
- Waterland RA , TravisanoM, TahilianiKG, RachedMT, MirzaS. Methyl donor supplementation prevents transgenerational amplification of obesity. Int. J. Obes. (Lond.)32(9) , 1373–1379 (2008).
- Wang J , WuZ, LiDet al. Nutrition, epigenetics, and metabolic syndrome. Antioxid. Redox Signal. doi:10.1089/ars.2011.4381 (2012) (Epub ahead of print).
- Friso S , ChoiSW, GirelliDet al. A common mutation in the 5,10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate status. Proc. Natl Acad. Sci. USA 99(8) , 5606–5611 (2002).
- Grundy S , CleemanJ, DanielsSet al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement: executive summary. Crit. Pathw. Cardiol. 4(4) , 198–203 (2005).
- Andreasen NC , PresslerM, NopoulosP, MillerD, HoBC. Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs. Biol. Psychiatry67(3) , 255–262 (2010).
- Orrell A , DohertyP, MilesJ, LewinR. Development and validation of a very brief questionnaire measure of physical activity in adults with coronary heart disease. Eur. J. Cardiovasc. Prev. Rehabil.14(5) , 615–623 (2007).
- Lahiri DK , NurnbergerJI Jr. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res.19(19) , 5444 (1991).
- Marsh S , KingCR, GarsaAA, McLeodHL. Pyrosequencing of clinically relevant polymorphisms. Methods Mol. Biol.311 , 97–114 (2005).
- Pilsner JR , HuH, EttingerAet al. Influence of prenatal lead exposure on genomic methylation of cord blood DNA. Environ. Health Perspect. 117(9) , 1466–1471 (2009).
- Zhang FF , CardarelliR, CarrollJet al. Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood. Epigenetics 6(5) , 623–629 (2011).
- McEvoy JP , MeyerJM, GoffDCet al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr. Res. 80(1) , 19–32 (2005).
- Roseboom TJ , PainterRC, van Abeelen AF, Veenendaal MV, de Rooij SR. Hungry in the womb: what are the consequences? Lessons from the Dutch famine. Maturitas70(2) , 141–145 (2011).
- Dempster EL , PidsleyR, SchalkwykLCet al. Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder. Hum. Mol. Genet. 20(24) , 4786–1496 (2011).
- Bentley TG , WillettWC, WeinsteinMC, KuntzKM. Population-level changes in folate intake by age, gender, and race/ethnicity after folic acid fortification. Am. J. Public Health96(11) , 2040–2047 (2006).
- Ursini G , BollatiV, FazioLet al. Stress-related methylation of the catechol-O-methyltransferase Val 158 allele predicts human prefrontal cognition and activity. J. Neurosci. 31(18) , 6692–6698 (2011).
- Murphy BC , O‘ReillyRL, SinghSM. Site-specific cytosine methylation in S-COMT promoter in 31 brain regions with implications for studies involving schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet.133B(1) , 37–42 (2005).
▪ Websites
- Examining risk factors for atypical antipsychotic metabolic side effects. http://clinicaltrials.gov/ct2/show/NCT00815854
- Pyrosequencing. www.pyrosequencing.com